key: cord-0857795-606bi2qk authors: Habtemariam, Solomon; Berindan‐Neagoe, Ioana; Cismaru, Cosmin Andrei; Schaafsma, Dedmer; Nabavi, Seyed Fazel; Ghavami, Saeid; Banach, Maciej; Nabavi, Seyed Mohammad title: Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID‐19: Shoot the messenger! date: 2020-07-17 journal: J Cell Mol Med DOI: 10.1111/jcmm.15652 sha: 9d09095cbd76d64d898ce38870097ad47d19094c doc_id: 857795 cord_uid: 606bi2qk nan frames (ORFs) that play an essential role in viral pathogenicity and infection. [1] [2] [3] Based on previous experiences with other coronaviruses, ORFs are considered to be essential for viral replication through encoding viral replicase proteins to synthesize mRNAs of subgenomic length. 1 FRhk-4 cells. 11 In addition to synergistic effects that may be exhibited by different siRNAs, their therapeutic action can synergize with other currently existing antiviral agents through direct or indirect targeting common structural genes or other cellular targets. 11, 12 In principle, several proteins encoded by the viral genome can be targeted by siRNA technology. 13 He et al 14 The authors declare no competing interests. MERS-CoV accessory ORFs play key role for infection and pathogenesis Genomics functional analysis and drug screening of SARS-CoV-2. Genes Dis Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice Prophylactic and therapeutic effects of small interfering RNA targeting SARS coronavirus Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque Inhibition of SARS-associated coronavirus infection and replication by RNA interference Attenuation of SARS coronavirus by a short hairpin RNA expression plasmid targeting RNA-dependent RNA polymerase Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference Inhibition of SARS-CoV replication by siRNA Application of siRNA against SARS in the Rhesus macaque model Development of interfering RNA agents to inhibit SARS-associated coronavirus infection and replication mRNA display design of fibronectin-based intrabodies that detect and inhibit severe acute respiratory syndrome coronavirus nucleocapsid protein Inhibition of SARS-CoV replication cycle by small interference RNAs silencing specific SARS proteins, 7a/7b, 3a/3b and S Kinetics and synergistic effects of siRNAs targeting structural and replicase genes of SARS-associated coronavirus Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs Design of potential RNAi (miRNA and siRNA) molecules for Middle East respiratory syndrome coronavirus (MERS-CoV) gene silencing by computational method siRNA silencing of angiotensin-converting enzyme 2 reduced severe acute respiratory syndrome-associated coronavirus replications in Vero E6 cells Knocking down disease: a progress report on siRNA therapeutics Silencing or stimulation? siRNA delivery and the immune system 3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways RNA interference therapy in lung transplant patients infected with respiratory syncytial virus A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus Coronavirusesdrug discovery and therapeutic options